Getein Biotech, Inc.SSE: 603387

Report for Q3 2025

· Issued by Getein Biotech, Inc. via Shanghai Stock Exchange

Filed with SSE ·

Report for Q3 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Getein Biotech, Inc. on 6ix

Earlier from Getein Biotech

Later from Getein Biotech

All Getein Biotech news releases